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Introduction
Familial Mediterranean fever (FMF) is an auto-inflammatory
disorder characterized by self limited attacks of fever
and serositis. The disease expression may be different in
different ethnic groups and patients with certain MEFV
mutations may be prone to have more severe disease
and a greater probability of developing amyloidosis (1).
Recently we showed that amyloidosis is the only predic-
tor of mortality in Turkish FMF patients (2), however
clinical subtypes with different clinical and genetic char-
acteristics have been never identified previously.
Objectives
The aim of this study was to evaluate whether there are
clinical subgroups, which may have different prognosis,
among FMF patients.
Methods
The cumulative clinical features of a large group of FMF
patients (1168 patients, 575 female [49.2%] and mean
age was 35.3 ± 12.4 years) were studied. To analyse our
data and identify groups of FMF patients with similar
clinical characteristics, a two-step cluster analysis using
log-likelihood distance measures was performed. For
clustering the FMF patients, we evaluated the following
variables: gender, current age, age at symptom onset,
age at diagnosis, the presence of major clinical features
(fever, peritonitis, pleuritis, arthritis, erysipelas like
erythema [ELE], febrile myalgia, amyloidosis), variables
related with therapy (the dosage of colchicine, compliance
with therapy, and the presence of attacks despite colchi-
cine), the family history for FMF and for renal failure and
the presence of M694V allele.
Results
Three distinct groups of FMF patients were identified.
Cluster 1 was characterized by high prevalence of arthritis,
pleuritis, ELE, and febrile myalgia. The dosage of colchi-
cine and the frequency of amyloidosis were lower in clus-
ter 1. Patients in cluster 2 had earlier age at symptom
onset and diagnosis. Other characteristics of cluster 2
were high frequency of arthritis, amyloidosis, M694V allele
and family history for FMF. This group of patients was
using highest dose of colchicine. The cluster 3 was charac-
terized by the lowest frequency of M694V allele, ELE,
arthritis, protracted febrile myalgia. The colchicine resis-
tance was also lower in cluster 3. The mean age and age at
diagnosis was the highest in cluster 3.
Conclusion
Patients with FMF could be clustered into distinct patterns
of clinical and genetic manifestations and these patterns
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